您的位置:首页 > 产品中心 > 65-28-1, 酚妥拉明 甲磺酸盐
酚妥拉明 甲磺酸盐
Phentolamine methanesulfonate salt
产品价格查看更多规格...
产品编号 | 包装单位 | 单价(元) | 国内现货 | 国外库存 | 询价单 |
3180998 | 100 MG | 1580 | |||
3180998 | 500 MG | 4180 |
产品别名
65-28-1
酚妥拉明 甲磺酸盐
Phentolamine methanesulfonate salt
2-(N-[m-Hydroxyphenyl]-p-toluidinomethyl)imidazoline
2-(N-[m-羟基苯基]-p-甲苯氨基甲基)咪唑啉
结构式
基本信息
Linear Formula【线性分子式】 | C17H19N3O · CH3SO3H |
Molecular weight | 377.46 |
EC number【EC 号】 | 200-604-6 |
MDL number | MFCD00134201 |
PubChem Substance ID【PubChem化学物质编号】 | 24277798 |
NACRES | NA.77 |
Biochem/physiol Actions【生化/生理作用】 | α-肾上腺素受体拮抗剂;外周血管舒张剂。 |
Features and Benefits【特点和优势】 | This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here. |
产品性质
Quality Level【质量水平】 | 200 |
Assay【测定】 | ≥98% (TLC) |
form【形式】 | powder |
color【颜色】 | white to off-white |
mp | 180-182 ℃ (lit.) |
solubility【溶解性】 | ethanol: 26 mg/mL H2O: 50 mg/mL |
originator【创始人】 | Novartis |
SMILES string | CS(O)(=O)=O.Cc1ccc(cc1)N(CC2=NCCN2)c3cccc(O)c3 |
InChI | 1S/C17H19N3O.CH4O3S/c1-13-5-7-14(8-6-13)20(12-17-18-9-10-19-17)15-3-2-4-16(21)11-15;1-5(2,3)4/h2-8,11,21H,9-10,12H2,1H3,(H,18,19);1H3,(H,2,3,4) |
InChI key | OGIYDFVHFQEFKQ-UHFFFAOYSA-N |
Gene Information | human ... ADRA1A(148), ADRA1B(147), ADRA1D(146), ADRA2A(150), ADRA2B(151), ADRA2C(152) |
packaging【包装】 | 100, 500 mg in poly bottle |
安全信息
Pictograms【象形图】 | GHS07 |
Signal word【警示用语:】 | Warning |
Hazard Statements | H302 - H315 - H319 - H335 |
Precautionary Statements | P261 - P264 - P270 - P301 + P312 - P302 + P352 - P305 + P351 + P338 |
Hazard Classifications【危险分类】 | Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 |
Target Organs【靶器官】 | Respiratory system |
Storage Class Code【储存分类代码】 | 11 - Combustible Solids |
WGK | WGK 3 |
Personal Protective Equipment【个人防护装备】 | dust mask type N95 (US), Eyeshields, Gloves |